Texas judge fines New York doctor for prescribing abortion pills to a woman near Dallas
A Texas judge on Thursday ordered a New York doctor to pay more than $100,000 in penalties for prescribing abortion pills to ...
UroToday19h
ASCO GU 2025: Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer
The primary study objective was to evaluate the prognostic value of post-therapeutic SPECT by RECIP 1.0 for overall survival.
UroToday2h
ASCO GU 2025: Understanding Patient Perspectives in the Management of Their Muscle-Invasive Bladder Cancer
Patient perceptions about their treatment for muscle-invasive bladder cancer (MIBC) over the last decade. Dr. Chowdhury began his presentation by emphasizing that muscle-invasive bladder cancer (MIBC) ...
UroToday5h
ASCO GU 2025: Safety Profile of Lutetium-177 in Patients with Impaired Renal Function: A Retrospective Analysis of Adverse Events in mCRPC Treatment.
Safety profile of lutetium-177 in patients with impaired renal function: A retrospective analysis of adverse events in mCRPC treatment. Dr. Saylani highlighted that Lutetium-177 vipivotide tetraxetan ...
UroToday7h
ASCO GU 2025: Effectiveness and Safety of Radium-223 in Men with mCRPC: A Systematic Literature Review of 48 Real-world Studies
From 1,085 citations identified, 48 studies with 15,368 men with mCRPC met inclusion criteria. Most studies were retrospective cohorts (n = 39) from Europe (n = 22) and North America (n = 18), with ...
UroToday7h
ASCO GU 2025: Creative Innovation: Driving Science to Improve Patient-Centered Care
(UroToday.com) The 2025 American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA was host to the Keynote Presentation. Dr. William Dahut discussed how ...